294 related articles for article (PubMed ID: 8993016)
1. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis.
Zhang K; Gharaee-Kermani M; McGarry B; Remick D; Phan SH
J Immunol; 1997 Jan; 158(2):954-9. PubMed ID: 8993016
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
3. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
[TBL] [Abstract][Full Text] [Related]
4. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
5. Lung cytokine production in bleomycin-induced pulmonary fibrosis.
Phan SH; Kunkel SL
Exp Lung Res; 1992; 18(1):29-43. PubMed ID: 1374023
[TBL] [Abstract][Full Text] [Related]
6. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis.
Epperly MW; Travis EL; Sikora C; Greenberger JS
Biol Blood Marrow Transplant; 1999; 5(4):204-14. PubMed ID: 10465100
[TBL] [Abstract][Full Text] [Related]
7. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
8. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
Yamamoto T; Takagawa S; Katayama I; Nishioka K
Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
[TBL] [Abstract][Full Text] [Related]
9. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
[TBL] [Abstract][Full Text] [Related]
10. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
11. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
12. Increased TGF-beta1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNF-alpha receptor knockout mice.
Liu JY; Brody AR
J Environ Pathol Toxicol Oncol; 2001; 20(2):97-108. PubMed ID: 11394717
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of transforming growth factor-beta 1 in a mouse model of immune-induced lung fibrosis.
Denis M
Immunology; 1994 Aug; 82(4):584-90. PubMed ID: 7835921
[TBL] [Abstract][Full Text] [Related]
14. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
16. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
17. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
Baecher-Allan CM; Barth RK
Reg Immunol; 1993; 5(3-4):207-17. PubMed ID: 7694632
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
[TBL] [Abstract][Full Text] [Related]
19. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.
Gurujeyalakshmi G; Wang Y; Giri SN
J Pharmacol Exp Ther; 2000 Apr; 293(1):82-90. PubMed ID: 10734156
[TBL] [Abstract][Full Text] [Related]
20. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.
Zhang K; Gharaee-Kermani M; Jones ML; Warren JS; Phan SH
J Immunol; 1994 Nov; 153(10):4733-41. PubMed ID: 7525714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
